“Efficacy and Safety of Bevacizumab in Neoadjuvant and Concurrent Chemoradiotherapy for Refractory Cervical Cancer Patients”. 2024. Biomolecules and Biomedicine, May. https://doi.org/10.17305/bb.2024.10528.